As IVF demand rises globally, particularly in fast-growing markets like India, clinics are under pressure to improve success rates while scaling efficiently and controlling costs. Variability in critical lab processes, such as egg freezing, continues to impact outcomes and patient confidence. In this exclusive conversation, Hans Gangeskar, CEO of Overture Life, discusses with Dr. Asawari Savant from Elets News Network (ENN) how automation and microfluidics could redefine consistency, affordability, and future standards in embryology labs. Edited excerpts

How does DaVitri reduce variability in freezing outcomes compared to manual methods performed by even highly skilled embryologists?

Egg freezing is one of the most technically sensitive steps in IVF. In a manual process, an embryologist must manage precise timing, chemical concentrations, and constant agitation over a 15-minute window. Small variations in timing or exposure can impact survival and downstream embryo development. DaVitri replaces that variability with a controlled microfluidic system. The eggs remain in a fixed position while precisely calibrated concentrations of cryoprotectants flow over them in a reproducible sequence. This ensures every cycle follows an identical protocol, eliminating operator-dependent variation and improving consistency across clinics.

Looking ahead, how scalable is DaVitri for markets like India, where IVF demand is rising rapidly?

DaVitri was designed specifically to scale. Traditional IVF labs require substantial infrastructure investment and highly specialised staff. That limits how quickly new labs can be built. DaVitri reduces infrastructure requirements and standardises a critical bottleneck in the process. This enables both centralised labs and smaller clinics to expand capacity without proportionally increasing staffing. In high-growth markets like India, scalability is essential to meeting rising demand.

How do you see DaVitri influencing future IVF lab standards and best practices globally?

IVF outcomes still vary significantly between operators and labs. Success rates can differ even between embryologists within the same clinic. By standardising vitrification under controlled, data-driven protocols, DaVitri moves the field toward reproducibility and measurable quality benchmarks. Over time, I believe automation will become the expected standard in embryology labs, not the exception. Consistency and traceability will increasingly define best practice.

Also read: Pioneering Excellence: Agilus Diagnostics Leading the Way in Cutting-Edge Healthcare Solutions

India is known to be a cost-sensitive healthcare market. How was DaVitri designed to balance advanced automation with affordability and scalability?

From the beginning, our primary objective has been lowering the cost of IVF. We cannot put million-dollar equipment into thousands of clinics and expect access to expand. DaVitri is compact, requires far less infrastructure than a traditional setup, and reduces the need for highly manual labour during a complex procedure. By improving throughput and consistency while lowering capital requirements, we help clinics deliver advanced care at lower per-cycle costs.

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!